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Abstract 
 
in vitro studies have shown that Drosophila melanogaster has a highly efficient single 
deoxyribonucleoside kinase (dNK) multisubstrate enzyme. dNK is related to the mammalian 
Thymidine Kinase 2 (TK2) group involved in the nucleotide synthesis salvage pathway. To study the 
dNK function in vivo, we constructed transgenic Drosophila strains and impaired the nucleotide de 
novo synthesis pathway, using antifolates such as aminopterin. Our results show that dNK over-
expression rescues both cell death and cell cycle arrest triggered by this anti-cancer drug, and confers 
global resistance on the fly. Moreover, we show that fly viability and growth depend on the exquisite 
ratio between dNK expression and its substrate thymidine (dT) in the medium, and that increased dT 
concentrations trigger apoptosis and a decrease in body mass when dNK is mis-expressed. Finally, 
dNK expression, unlike that of TK2, is cell cycle dependent and under the control of CyclinE and the 
dE2F1 transcription factor involved in the G1/S transition. dNK is therefore functionally more closely 
related to mammalian TK1 than to TK2. This strongly suggest that dNK plays a role in cell 
proliferation in physiological conditions. 
 
Running title  
in vivo study of Drosophila dNK 
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Introduction 
 
In the cell, the building blocks of DNA biosynthesis (deoxyribonucleotides) are provided 
through both de novo and salvage pathways. The mammalian deoxyribonucleoside kinases are 
deoxycytidine kinase (dCK), thymidine kinase 1 (TK1) and 2 (TK2) and deoxyguanosine 
kinase (dGK). These enzymes phosphorylate deoxyribonucleosides and thereby provide an 
alternative to de novo synthesis of DNA precursors. The salvage pathway is a complementary 
route for providing cells with DNA precursors, primarily utilizing uptake of 
deoxyribonucleosides from the extracellular space, derived from nutrients or degraded DNA 
(see Fig 1). These deoxyribonucleosides enter the cell membrane by facilitated diffusion via a 
nucleoside carrier protein with a wide specificity.1 Nevertheless, the salvage pathway is not a 
prerequisite for cell survival in replicating mammalian cells, since the de novo synthesis can, 
in principle, provide all the DNA precursors necessary for cell growth. Under normal culture 
conditions, neither the viability nor the growth of cells seems to require the uptake of 
exogenous deoxynucleosides. Nevertheless, the salvage pathways do have important roles.2 In 
mammals, TK1 is cell cycle regulated, whereas TK2, a mitochondrial enzyme, is no.3 
Moreover, mutations in genes of the salvage pathway are responsible for various human 
diseases. Several TK2 mutations have been linked to severe skeletal myopathy in infancy due 
to mitochondrial DNA depletion.4 In addition, Herpes Simplex Virus TK (HSV-TK) acts as 
activator of various pro-drugs.5 
In Drosophila and other insects, only one member of the deoxyribonucleoside kinase family 
(dNK) that displays broad substrate specificity as well as a very high catalytic rate can be 
found.6-8 The Drosophila enzyme can indeed phosphorylate the four deoxynucleosides and 
many therapeutical cytotoxic nucleoside analogs with a higher turnover than other known 
viral and mammalian kinases (see Fig 1).7, 9, 10 Hence, these features make the Drosophila 
enzyme a unique member (EC 2.7.1.145) of the nucleoside kinase enzyme family. As for its 
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phylogeny, dNK belongs to the TK2, deoxycitidine kinase (dCK), deoxyguanosine kinase 
(dGK) and the Herpes viral thymidine kinase family, and is not so closely related to TK1.6 
The exact functions in vivo of the Drosophila enzyme, however, are still unknown, especially 
those in proliferation and apoptosis. Here we show that dNK expression is associated with 
proliferating cells and under the control of the dE2F1 transcription factor. To understand the 
function of Drosophila dNK in vivo, we constructed transgenic Drosophila strains that allow 
ectopic or over-expression of dNK. We observed that dNK over-expression, when the de novo 
pathway is inhibited by antifolates such as methotrexate (MTX) and aminopterin (AM), 
rescues cell death induced by the drugs in the wing imaginal disc. Moreover, dNK over-
expression confers on the flies global resistance to these anti-cancer drugs. We show that this 
is caused by both a decrease in cell death and a stimulation of cell cycle progression. In 
addition, the viability of the flies depends on the exquisite ratio between dNK expression and 
thymidine (dT) concentration in the medium. This nucleoside induces cell death when dNK is 
over- or under-expressed and a drastic body mass decrease in this latter genotype.  
 
Materials & Methods 
Drosophila strains and media 
The Wild type Canton S, w1118, engrailed-GAL4 (en-GAL4), patched-GAL4 (ptc-GAL4) and 
daughterless-GAL4 (da-GAL4) strains come from the Bloomington Drosophila stock center 
(Indiana University). The vg-GAL4 strain that drives GAL4 expression according to part of 
the vgBE enhancer was provided by S. Carroll. The UAS-CycE, UAS-RBF1 and UAS-dE2F1, 
UAS-DP, UAS-P35 strains were provided by B. Edgar.12 The UAS-dNK strain was generated 
in our laboratory. The deficiency covering dNK comes from the Bloomington center (Df(3R) 
n°5600). Aminopterin (AM), Methotrexate (MTX) or Thymidine (dT) (Sigma) were added to 
the medium depending on the experiment. 
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Histology 
Images were acquired with a Leica TCS-SP confocal microscope or a Leica DMR microscope 
equipped with a DXM 1200 (Nikon) digital camera, and processed with Adobe Photoshop or 
Image J softwares. Dissections and immunochemistry were performed according to 42. 5-
Bromo-2’-deoxyuridine (BrdU) and 4'-6-Diamidino-2-phenylindole (DAPI) labeling of 
imaginal discs was performed as described.15 Digoxigenin (DIG)-labeled antisense or sense 
RNA probes were generated with T3 or T7 RNA polymerase (Promega) and DIG-UTP 
(Roche), from cloned cDNAs of dNK. These probes were used for whole mount in situ 
hybridization of fixed larval imaginal discs. The DIG-labeled RNA probes were detected with 
the aid of an anti-DIG antibody coupled with alkaline phosphatase (Roche) and NBT/BCIP as 
substrate.43 Stainings with TUNEL Reagent (Roche), rabbit polyclonal anti-dNK antibodies 
(1:1000) (gift from W. Knecht & J. Piskur)11, mouse monoclonal (n°8B10) anti-CyclinE 
antibody (1:1) (gift from H. Richardson) 44 and rabbit polyclonal CM1 anti-activated caspases 
antibodies (1:5000) (BD Pharmingen) were performed according to standard protocols.  
 
Fluorescence-activated cell sorter (FACS) experiments 
Staged larvae (120 h AED) derived from 2-3h egg collections and raised at 25°C were 
dissected in PBS for each genotype. Twenty wing discs were washed twice in PBS and 
incubated with gentle agitation in trypsin (Invitrogen) and Hoechst 33342 (Sigma) for 150 
min according to Neufeld et al12. About 20 000 GFP+ and GFP- cells were analyzed for each 
genotype. An Elite Beckman Coulter FACS was used and data were analyzed using the 
Multicycle Software.  
 
Quantitative RT-PCR analysis 
RNA from third instars larvae were extracted with Gibco BRL trizol reagent kit. First strand 
cDNA was synthesized with oligo-dT primer and AMV reverse transcriptase according to the 
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manufacturer’s instructions (Pharmacia). RT-PCR amplification mixture (10 µl) contained 
1/20 of cDNA product, 10X SIBR Green I Master Mix buffer and 100 ng forward and reverse 
primers. Reactions were run on a Light Cycler PCR apparatus (Roche) Cycle condition were 
10 min at 95°C and 45 cycles at 95°C for 10 sec, 60°C (RP49, dE2F1) or 65°C (dNK) for 10 
sec and 72°C for 10 sec. Each assay included a standard curve of 3 serial dilution points of 
wild type third instar larvae cDNA (ranging from 100 ng to 1 ng). All PCR efficiencies were 
above 95% . The expression of dE2F1 and of dNK was quantified relative to rp49. Each point 
was repeated three times. Primers for rp49 amplification were : forward primer 5’-
CCGCTTCAAGGGACAGTATCTG, reverse primer: 5’- CACGTTGTGCACCAGGAACTT, primers for 
dE2F1 amplification were : forward primer 5’-CAATGACTATCCGTATGCGCTGA, reverse primer: 
5’TTCGTGGACGTCTCCTCTTAGG, primers for dNK amplification were : forward primer 5’-
TAGTCCTCGATGCCGATCTGA, reverse primer: 5’-GATAATGGTTATCTGGCGACCCT. Differences in 
dNK and dE2F1 cDNA concentrations were adjusted by normalizing to RP49. For each gene, 
values were averaged over at least three independent measurements. Three independant RNA 
isolation experiments were performed for all genotypes and means were calculated. 
 
Results 
dNK is expressed in proliferating cells 
First, the dNK pattern of expression was assessed in the wing and eye imaginal discs by in 
situ hybridization, and immunochemistry with anti-dNK antibodies.11 Imaginal discs provide 
useful model systems for the study of developmental control of proliferation.12 In late 3rd 
instar wing discs, proliferation occurs uniformly, but in the Zone of Non-proliferation Cells 
(ZNC) along the Dorsal/Ventral boundary, where cells undergo precocious cell cycle arrest, 
prior to differentiation.13-16 In mid-late 3rd instar wing imaginal discs, a quite uniform dNK 
expression (both transcripts and proteins) was observed (Fig 2A,C). A few hours later, in late 
3rd instar wing discs, once the ZNC is completely established, dNK expression is clearly 
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down-regulated in ZNC arrested cells that no longer incorporate the S-phase marker : BrdU 
(Fig 2D). In the eye disc, dNK expression (both transcripts and proteins) is mainly associated 
with the cells immediately posterior to the morphogenetic furrow that are about to enter the S 
phase of the second mitotic wave (Fig 2B,E). We further confirmed this using anti-cyclinE 
antibodies that enable to distinguish the morphogenetic furrow (Fig 2E). These observations 
suggest that dNK expression may be cell cycle-regulated and involved in cell proliferation 
under normal conditions, whereas its closest mammalian homologue TK2 is believed not to 
be proliferation-dependent.1  
Mammalian deoxyribonucleoside kinases have been identified in distinct sub-cellular 
compartments of the cells. Drosophila dNK might have both mitochondrial and nuclear 
import signals.17 dNK transfection experiments in mammalian cells with hybrid protein 
constructs, indicate a nuclear localization for the enzyme. Indeed, nuclear addressing 
sequences have been identified in the C-terminal domain of the protein.9 Surprisingly, in 
Drosophila wing discs, only a cytoplasmic localization was observed by immunochemistry 
(Fig 2C). These discrepancies suggest that dNK transfection experiments in heterologous cells 
represent specific conditions that may only partly correspond to the physiological localization 
of the protein. Double staining experiments using the mito-trackerTM reagent or UAS-mito-
GFP transgenic strains (see reference 18) and dNK antibodies in the salivary gland or wing 
disc peripodial cells of third instar larvae, where mitochondria are easily visualized, did not 
show any clear overlap (data not shown). Since no specific mitochondrial localization has 
been identified so far, it is still unclear whether the salvage enzymes are present in insect 
mitochondria or whether mtDNA replication and repair rely on the import of 
deoxyribonucleoside mono-, di- and/or tri-phosphates from cytoplasm. 
 
dNK is under the control of the dE2F1 transcription factor 
The broad substrate specificity and sequence analysis both show that the Drosophila enzyme 
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is more closely related to human mitochondrial TK2 than to the other mammalian 
deoxyribonucleosides kinases.6, 17 But since Drosophila dNK seems to be associated with 
proliferating cells, we hypothesized that, like TK1 in mammalian cells, dNK is 
developmentally regulated by E2F1, the transcription factor that regulates expression of 
different genes involved in G1/S transition and DNA replication.3, 19 Therefore, in order to 
test this postulate, we expressed dE2F1 ectopically using the UAS-GAL4 system described 
in.20 In this system, two transgenic strains are crossed, one expressing the yeast GAL4 
transcription factor in a specific pattern and the other carrying UAS sequences upstream of 
the gene of interest. The binding of GAL4 on UAS sequences will trigger the ectopic 
expression of the gene of interest in this tissue. We expressed dE2F1 according to the patched 
(ptc) domain in the wing disc, using the UAS-dE2F1, UAS-DP, UAS-P35 strain, which makes 
dE2F1-DP expression possible without triggering apoptosis.12 The ptc-GAL4 driver enables 
strong expression along the Anterior-Posterior compartment boundary. In situ hybridization 
revealed a strong induction of dNK transcripts according to the ptc pattern, indicating that 
dNK is regulated by dE2F1 in Drosophila (Fig 3A). This observation was confirmed at the 
protein level (Fig 3B, where the ptc domain is labelled by GFP expression). Similar results 
were also observed with cyclinE, which positively regulates dE2F1 activity (Fig 3C). To 
confirm that Drosophila dNK is under the control of the dE2F1 transcription factor, we 
ectopically expressed the retinoblastoma protein (RBF1), a cell cycle progression inhibitor, 
according to the ptc domain. RBF1 binds the dE2F1 protein, inhibiting transcriptional 
activation of dE2F1 target genes involved in proliferation.21 dNK down-regulation in 
response to RBF1 expression was observed (Fig 3D), indicating that dE2F1 function is 
required for dNK expression. Altogether, these results indicate that, unlike the TK2 enzyme, 
dNK expression is associated with proliferating cells and is under the control of dE2F1 and is 
therefore functionally more closely related to mammalian TK1.  
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dNK expression and de novo biosynthesis inhibition 
To understand the role of dNK in the Drosophila salvage pathway we decided to impair the de 
novo pathway using antifolates such as AM or MTX that inhibit dihydrofolate reductase 
(DHFR) activity and thus the de novo thymidylate (dTMP) synthesis. MTX is widely used in 
chemotherapy, mainly in the treatment of childhood acute lymphoblastic leukemia. MTX-
induced inhibition of DHFR depletes the tetrahydrofolate pool, thus decreasing purine and 
pyrimidine nucleotide biosynthesis and contributing to a proliferation arrest and cell death 
(seeFig 1).22 In mammals, no rescue of the effects of MTX administration by TK1 or TK2 has 
been reported, probably because an imbalance of purine and pyrimidine nucleotides triggers 
cell death. Indeed, rescue from folate depletion by addition of both purine and pyrimidine 
nucleosides have been reported in megaloblastic anemia.23 
In Drosophila, however, there exists an unique deoxynucleoside kinase that can 
phosphorylate all nucleosides. In order to assess the role of dNK in the salvage pathway, we 
generated transgenic strains allowing ectopic or over-expression of dNK. The Drosophila 
dNK cDNA was cloned in the P-Casper vector and the resulting UAS-dNK construct injected 
into Drosophila embryos. Nine independent transgenic Drosophila lines were generated. e.g. 
dNK over-expression in the wing disc, according to the ptc-GAL4 driver, is shown in Fig. 3E. 
These strains made it possible to perform Gain Of Function experiments (GOF). In addition, a 
heterozygous deficiency encompassing the dNK gene was used to unravel Loss Of Function 
(LOF) phenotypes, since no mutants are as yet available. This hypomorphic strain displays 
normal viability, but the dNK transcriptional level, assessed by quantitative RT-PCR, is 
decreased by 25% (data not shown). To ascertain that the observed LOF phenotypes were due 
to dNK decrease and not from another gene deleted in the deficiency, we constructed a UAS-
dNK, df(dNK)/+ strain, in order to rescue the phenotypes observed with the LOF strain. 
We decided to use the wing imaginal disc to assess the putative role of dNK when the de novo 
pathway is inhibited. As previously mentioned, the Drosophila wing disc is a highly 
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proliferating tissue that provides a relevant model for genetic studies.12, 15 Therefore, we over-
expressed dNK in the vestigial (vg) expression domain that determines the future wing 
margin, and looked at the wing phenotype when control or df(dNK)/+ flies were reared on 
normal or AM-containing medium (1mg/kg). This latter compound induces cell death and 
decreases cell proliferation in the wing disc.24 Since AM blocks the de novo synthesis 
pathway, any functional interaction between addition of AM and impairment of the salvage 
pathway (df(dNK)/+ deficiency) should specifically result from down-expression of the 
salvage enzyme dNK. When reared on AM, control flies displayed nicks in their wings (Fig 
4A). The wings of df(dNK)/+ flies were even more often affected, demonstrating the 
deleterious effect of de novo and salvage pathways concomitant inhibition. Nevertheless, the 
wing phenotypes observed in both the control and the df(dNK)/+ Drosophila were greatly 
rescued by dNK over-expression along the wing margin (Fig 4A). None of these flies 
displayed any abnormal wing phenotype on normal medium. These results demonstrate that 
the wing phenotype of df(dNK)/+ flies reared on AM is greatly dependent on the specific 
down-expression of dNK in this strain.  
Since dNK is also specifically expressed in the cells of the eye that are entering S phase (Fig 
2B,E), we looked for eye phenotypes, adding AM to the medium during fly development. AM 
treatment did not impair eye development in the control strain, but specifically reduced eye 
size in the df(dNK)/+ strain (Fig 5A,B,D,E). Moreover, this phenotype was completely 
rescued when dNK was expressed under the control of the ubiquitous daughterless-GAL4 (da-
GAL4) driver (Fig 5C,F). Similar results were obtained with another antifolate : MTX (data 
not shown). This suggests that dNK is required for eye growth when the de novo pathway of 
nucleotide synthesis is inhibited. 
At this stage, it was not possible to determine whether dNK over-expression prevents drug-
induced apoptosis or stimulates cell proliferation, since both cell death and lack of 
proliferation induce nicks in the wings and abnormal eyes.24-26 To test the effect of dNK on 
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apoptosis induced by AM, we looked initially for apoptosis, using (i) anti-activated-caspases 
antibodies, (ii) TUNEL experiments, in wing discs of flies grown on AM, where dNK was 
over-expressed under the control of the engrailed-GAL4 (en-GAL4) driver. This strain allows 
gene expression in the posterior (P) compartment of the wing disc, as visualized using a UAS-
GFP reporter construct (Fig. 4B). In the en domain, we observed almost no cell death using 
TUNEL staining (Fig 4C). This was confirmed with anti-activated caspase antibodies 
staining, indicating a strong rescue of apoptosis in the P compartment marked by GFP, while 
caspase activation was clearly observed in the anterior (A) part of the disc (Fig 4B). This 
indicates a strong rescue of apoptosis where dNK was over-expressed. This observation is 
striking when looking at the wings of en-GAL4 ; UAS-dNK adult flies grown on AM. Nicks at 
the level of the wing margin could be observed in the A compartment, while the P 
compartment displayed a wild type phenotype due to dNK over-expression (Fig. 4D). 
Together, these results demonstrate that dNK over-expression in vivo rescues wing cells from 
antifolates-induced apoptosis. 
 
dNK over-expression confers resistance to AM and MTX on the whole organism 
Next we wished to investigate whether the effect observed in proliferating tissues such as the 
wing or eye discs could be extended to the whole organism. Using the same da-GAL4 driver, 
which allows ubiquitous expression in all tissues from embryogenesis to the adult stage, we 
tested the survival of UAS-dNK and df(dNK)/+ flies compared to control, when reared on 
normal or AM-containing medium (Fig 4E). Our results clearly showed that AM treatment 
reduced the viability of the control strain. The viability of df(dNK)/+ flies was even further 
reduced. Nevertheless, dNK over-expression conferred resistance to AM on both control and 
df(dNK)/+ strains. We obtained similar results using another DHFR inhibitor : MTX 
(2mg/kg) (Fig 4E).  
To assess whether survival of dNK over-expressing flies on AM is due to resistance to 
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apoptosis and/or to an increase in cell proliferation, we chose to evaluate, by real time 
quantitative RT-PCR in third instar larvae, a major gene controlling cell proliferation : 
dE2F1, assuming that increased proliferation and an increased level of dE2F1 are correlated 
as previously reported.19 Interestingly, we found that AM dramatically repressed dE2F1 
expression in the control strain (Fig. 6A). This result is quite consistent with the recent 
demonstration of MTX-induced down-expression of many cell-cycle genes such as cyclinA or 
cyclinE in ovaries 27. dNK over-expression using the da-GAL4 driver had no effect on dE2F1 
expression compared to control on normal medium (Fig 6A), suggesting that, in normal 
conditions, dNK over-expression cannot induce over-proliferation, at least in larvae. 
Interestingly, dE2F1 down-regulation in response to AM treatment was significantly weaker 
when dNK was over-expressed using the same driver (Fig. 6A). The fact that dE2F1 was less 
repressed in the dNK over-expressing strain reared on the drug, suggests that dNK induces 
some proliferation in larvae fed with the drug. This may explain, at least partly, AM-
resistance at the level of the whole organism. Nevertheless, these experiments did not assess 
any post-transcriptional modulation of dE2F1, which has been previously described as an 
additional mechanism for dE2F1 regulation.28 We also investigated whether AM feeding had 
an effect on dNK expression. No difference in the dNK mRNA levels were observed in 
control Drosophila in presence or absence of AM (data not shown).  
Proliferation is commonly assessed by looking at S and M phases cells in tissues, by means of 
BrdU pulse experiments and anti-PhosphoHistone3 antibodies labeling, respectively. In our 
experiments, these methods did not give clear results. Indeed, both apoptosis and proliferation 
are probably involved in the process making it difficult to distinguish the role of dNK in 
proliferation when using this method.  
Nevertheless, to strengthen the previous results, we investigated the role of dNK on the cell 
cycle by means of cell sorter experiments using the wing disc model.12 GFP alone or together 
with dNK were over-expressed in the P compartment of the wing disc using the en-GAL4 
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driver. Cell cycle profiles of the P and A compartments cells were compared in control en-
GAL4, UAS-GFP discs when larvae were reared on normal or AM-containing medium (Fig 
6B1,B3). On normal medium the cell cycle profile was similar in both compartments. On AM, 
significant changes in the overall cycle were observed with, as expected, a dramatic decrease 
in the number of G2/M cells and an increase in the number of S phase arrested cells, albeit 
without significant differences between the A and P compartments. In addition, a significant 
amount of apoptotic nuclei could be observed. 
In a second experiment, dNK was over-expressed in the P compartment (Fig 6B2,B4). On 
normal medium, the content of S phase cells in the P compartment was slightly increased 
compared to that of the A compartment of the discs. It suggests that dNK over-expression can 
alter the normal cell cycle to some extent. When larvae were grown on AM, a significant shift 
towards G2/M was observed in the P compartment where dNK was over-expressed. The 
percentage of G2/M phase cells was even higher than on normal medium. Moreover, the 
quantity of apoptotic nuclei, as detected by DNA profile, was reduced. We also observed a 
partial cell cycle profile rescue in the adjacent A compartment of the disc. This suggests that 
dNK expression may have some non-autonomous effects on cell proliferation. One 
explanation may be that input of proliferation induced by dNK over-expression in the P 
compartment in turn activates morphogenetic events that control proliferation of both A and P 
compartments. 
Our results indicate that over-expression of dNK changes the cell cycle profile not only on 
normal but especially on AM-containing medium. It strongly suggests that dNK over-
expression allows flies to survive when reared on antifolate drugs, by decreasing apoptosis 
and allowing the cell cycle to proceed. These data show that dNK plays a key role when 
normal proliferation is perturbed in Drosophila. It also suggests that drugs inhibiting the 
dTMP pool such as AM and MTX, can dramatically enhance the potential activities of the 
Drosophila dNK enzyme.  
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dT concentration and dNK expression play a role in fly viability, growth and cell 
survival 
It has been shown that, among dNK substrates, only addition of the nucleoside thymidine 
(dT) can rescue the effect of AM-induced lethality, although this drug depletes both 
pyrimidine and purine nucleotide biosynthesis.29 We decided to evaluate the capacity of dT to 
rescue the effect of a high concentration of AM, which completely arrests the nucleotide de 
novo synthesis pathway. Therefore, we measured viability of flies on AM with increasing 
concentrations of dT during development. Low concentrations of dT (0.1 or 0.5g/kg) strongly 
rescued the viability of Drosophila reared on AM (10mg/kg) (Fig 7A). This underlines the 
importance of this nucleoside when the de novo biosynthesis is inhibited. At higher 
concentrations of dT (>1g/kg), the rescue was lost. Moreover, Drosophila viability 
progressively decreased. Lethality was also observed upon addition of dT (> 2g/kg), even 
without AM treatment (Fig 7A). This clearly demonstrates the toxicity of dT per se at high 
doses, although a slight synergistic effect of the two compounds (AM + dT) was visible (Fig 
7A). 
To date, our knowledge of the relationship in vivo between the enzyme (dNK) and its 
substrate (dT) is only slight. We wondered whether dNK could be regulated by this substrate 
in flies. Strikingly, both dNK over-expression (Fig 4,5) or dT addition can rescue the effect of 
AM on Drosophila. We decided to measure the effect of dT addition on dNK expression. 
Quantitative RT-PCR were performed and showed an increase in dNK transcripts in response 
to dT (Fig 7B), suggesting that the dNK promoter is inducible in the presence of the 
nucleoside. The maximum dNK induction (# x2) was obtained at 2.5g/kg without any further 
increase, at higher dT concentrations (5,6,10 g/kg, data not shown). 
We therefore assessed viability in Drosophila genetic contexts providing different dNK 
expression levels (LOF, control, GOF). In response to dT, even at a low dose (1g/kg), 
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df(dNK)/+ Drosophila displayed reduced viability, whereas the control strain remained 
almost unaffected until 2g/kg (dT) (Fig 7C). In addition, these df(dNK)/+ flies display 75% of 
the normal level of dNK transcripts, and only very weak dNK induction was observed in 
response to dT (Fig. 7B). One explanation could be that the remaining copy of the dNK 
promoter is not sufficient to support induction by dT and may already be fully activated in 
these df(dNK)/+ flies.  
In dNK over-expressing flies (da-GAL4, UAS-dNK), viability on dT was also assessed. 
Unexpectedly, they displayed a reduced survival rate compared to the control (Fig. 7C). Thus, 
in response to dT, both dNK LOF and GOF genotypes show similar viability profiles ; a 
developmental delay was also observed (data not shown). In these flies, accumulation of dT 
or intermediate dTTP synthesis products are probably toxic. As a whole, since dNK 
expression is coordinately increased in response to dT addition in the control strain (Fig. 7B), 
dNK mis-expression in LOF or GOF genotypes, may make the flies unable to adjust 
accurately dNK level to dT concentration. 
To understand the developmental delay and lethality observed in GOF and LOF flies 
compared to controls, we looked for possible alteration of a proliferating tissue, the wing disc. 
Some cell death was observed in third instar wing discs of the LOF genotype when grown on 
dT (Fig. 7D). A similar and more visible effect was detected in vg-GAL4, UAS-dNK wing 
discs (GOF), while almost no cell death was observed in wild type larvae in the same 
conditions (Fig. 7D). At this point, it was difficult to know whether this cell death induction 
was responsible for the lethality observed in LOF and GOF flies reared on dT-containing 
medium. 
dT concentration and dNK expression, however, bear a striking connection to fly tissue 
growth. Our results show a significant weight decrease in df(dNK)/+ emerging adults 
compared to controls when reared on increasing dT concentrations. At dT (2g/kg), weight was 
even reduced two fold (Fig 7E). This was confirmed when the pupae surface of the two 
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genotypes was estimated at different concentrations of dT (Fig 7F). The results are highly 
significant, and similar to those observed in mutants for cell growth regulators such as InR, 
chico and S6K (see references 30-32), indicating that major cellular events took place in the 
df(dNK)/+ heterozygotes and led to the reduction of body mass. 
 
Discussion 
 
Several studies demonstrate the crucial importance of deoxyribonucleotide regulation. The 
necessity for precisely regulated deoxyribonucleoside kinase function is emphasized by the 
fact that mutations in some genes of the salvage pathway in humans cause severe diseases. 
Indeed, in human, TK2 mutations are responsible for mitochondrial DNA depletion 
associated myopathy.4 Deoxyribonucleoside kinases are also key enzymes for the use of 
nucleoside analogs, such as fluorouracil (FU) and fluorodeoxyuridine (FudR) in 
chemotherapy (see Fig. 1).33 Moreover, deoxyribonucleoside kinases are used as activators 
for drug therapy in cancer and AIDS. For instance, HSV-TK makes cancer cells sensitive to 
the pro-drug ganciclovir and dNK transfection in cancerous lines increases cell sensitivity to 
cytotoxic nucleoside analogs, suggesting that this enzyme, like HSV-TK, could be used as a 
suicide gene in chemotherapy.9, 34 Only a few studies, however, have evaluated the role of 
these genes in vivo. Our goal was to use Drosophila as a model organism to study the 
relationship between the dNK enzyme and antifolates, and their influence on cell survival and 
proliferation. The study of Drosophila dNK function is also an important issue to understand 
how de novo and salvage pathways harmoniously achieve DNA replication.  
 
Antifolates resistance 
In order to shed light on the dNK function we decided (i) to construct transgenic strains over-
expressing dNK. (ii) We also used a heterozygous deficiency as a hypomorphic dNK context. 
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Moreover, dNK over-expression rescued the df(dNK)/+ phenotypes, confirming that they are 
specific to dNK loss of function. (iii) In addition, we inhibited the de novo nucleotide 
synthesis pathway using antifolates (AM, MTX). In mammals, this is commonly done in 
cancer treatment to stop proliferation and induce apoptosis of cancerous cells. Resistance to 
these drugs has been regularly reported and extensively studied.33 Resistance mechanisms 
vary in different cancers. Mainly, transport, efflux and polyglutamination of the drugs are the 
most often described. An increase in DHFR activity due to gene amplification or mutations in 
DHFR that decrease its affinity for the drug, have been observed in cell lines and also in 
tumors.33The involvement of any one of the four different deoxyribonucleoside kinases, 
however, has never been reported in MTX or AM resistance. This may be due to nucleotides 
imbalance, a major cause of DNA alteration and cell death.35, 36 Activation of only one of the 
several deoxyribonucleoside kinases would trigger this phenomenon in mammals. In 
Drosophila, dNK over-expression, without addition of nucleosides, rescued the effect of AM 
in the wing disc, both by decreasing apoptosis and restoring cell cycling. Indeed, under these 
circumstances, it is possible that dNK phosphorylates efficiently all the nucleosides required 
for functional DNA replication. This sheds light on the difference between mammals and 
Drosophila in the regulatory mechanisms used to achieve normal DNA replication through 
the de novo and salvage pathways.  
In the fruit fly, it has been previously reported that the effects of AM can be rescued by 
addition of dT in the medium with no further need for purine nucleosides.29 The reason for 
this could be either that AM blocks only or mainly the pyrimidine nucleotides biosynthesis in 
flies or that dT concentration is limiting compared to purine deoxyribonucleosides. This also 
implies that dNK activity increases when necessary. Moreover, we also showed that dT 
induces dNK expression, possibly strengthening the rescue from AM. 
In mammals, FUdR and FU (but not MTX) are rescued by addition of dT alone. Indeed, these 
two drugs inhibit thymidylate synthetase – this latter converts dUMP into dTMP - and do not 
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impair any other pathway (see Fig 1). However, so far, no resistance due to enhanced 
mammalian Thymidine Kinase (TK) activity has been observed in tumors. Interestingly, not 
only did dNK over-expression in Drosophila confer resistance to AM and MTX in the wing 
and eye discs, it also rescued the viability of the whole animal throughout its development. To 
our knowledge, this is the first time such a resistance has been described in an entire 
organism. Our data show that dNK over-expression enables AM-treated cells to proliferate 
and rescues these cells from apoptosis. Similar observations have been reported in 
heterologous HSV-TK transfection experiments in the mammalian interleukin-3 dependent 
pre-B cell line BAF3, where a delay in apoptosis induced by MTX has been observed.37 
 
dNK-dT relationship in Drosophila  
It has been shown recently that dNK, like TK1, is inhibited in a feedback loop by dTTP, a 
final product of the pathway (see Fig. 1)38, 39, confirming that dNK enzymatic activity is 
actively controlled. Our data show that the deleterious effects of high concentrations of AM 
are rescued by addition of low doses of dT, a dNK substrate. This confirms the importance of 
this nucleoside and its efficiency in the rescue of de novo pathway inhibition. On the other 
hand, higher concentrations of dT are toxic for the fly, for reasons that are still unclear but 
which probably involve apoptosis. This toxicity is also enhanced when dNK is mis-expressed. 
Normal development therefore requires a precise correlation between the level of this 
nucleoside in the medium and a specific level of dNK expression. 
Moreover, our results demonstrate that dT induces expression of the dNK gene in the wild 
type strain suggesting that the dNK promoter is responsive to dT. Given the inhibition of dNK 
activity by the final product dTTP, these results suggest that dNK expression and activity are 
indeed finely tuned in a homeostatic loop.  
Consistantly, in heterozygous df(dNK)/+ Drosophila, dNK is barely activated by dT ; this 
accurate regulation is lost. In a control strain, roughly a two fold maximum dNK induction is 
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obtained in response to dT. Nevertheless, the LOF strain contains only one copy of the dNK 
promoter that supports 75% of normal dNK transcription. This promoter is probably already 
greatly activated and cannot be induced any further. This may account for the very weak 
responsiveness of dNK heterozygotes.  
In addition, df(dNK)/+ phenotypes were enhanced by dT addition ; we therefore considered 
them to be dNK-specific. They reveal functional interactions between dT and dNK loss of 
function. We observed apoptotic cells in the wing dicscs of heterozygotes reared on 
increasing concentrations of dT. An excessive accumulation of unprocessed nucleoside may 
be responsible for the toxicity and cell death. dNK over-expression also induced lethality and 
significant cell death when flies were reared on dT. Therefore, both dNK over- and under-
expression trigger similar effects confirming that exquisite dNK regulation plays a key role in 
physiology of Drosophila during development. 
Moreover, in LOF Drosophila, even at low concentrations, addition of dT induced a high 
lethality rate associated with a two fold decrease in adult body mass. This latter effect is 
reminiscent of those observed in InR, chico and S6K mutants.30-32 Additional studies will be 
required to discover whether this striking effect is due to apoptosis, diminution of cell growth 
and/or cell proliferation. Particularly, the relationship between dT metabolism and pathways 
involved in growth regulation, like InR/FOXO, needs to be evaluated in wild type and in 
df(dNK)/+ flies. 
 
Potential role of dNK in cell proliferation 
In Drosophila, it is difficult to evaluate whether the salvage pathway is required for normal 
DNA replication or whether it is merely activated when the de novo pathway is inhibited. The 
wing and eye phenotypes observed in df(dNK)/+ flies grown on AM are, however, rescued by 
dNK over-expression. This argues in favour of a role for dNK in cell proliferation, in specific 
conditions when the de novo pathway is inhibited. When available, the use of a stronger dNK 
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mutant or RNAi, and the study of viability and phenotypes on a nucleoside free-medium 
should help to elucidate this point in the future. (i) Nevertheless, our results show that dNK  is 
expressed in proliferating cells. (ii) It is also positively regulated during development by 
dE2F1 which controls almost all genes involved in DNA replication and G1/S transition. (iii) 
Moreover dNK is down-regulated by RBF1. (iv) We also note that, in late 3rd instar wing dics, 
dNK expression is down-regulated at the ZNC (see Fig. 2D). Since dE2F1 has been shown to 
be lately inactive in this region, this might reflect the requirement of dE2F1 for dNK 
expression in the wing disc.14 Therefore, our data strongly suggests that dE2F1 function is 
necessary and sufficient for dNK expression and that dNK may be an actor of cell 
proliferation under normal conditions. Interestingly, before the dNK gene was characterized, 
it had been shown that ‘thymidine kinase’ activity in Drosophila Schneider cells is cell cycle 
regulated, with a peak activity during S phase, like human TK1.40 Nevertheless, TK1 activity 
is regulated at the (post)-translational level and is degraded during mitosis, while its 
transcription remains stable in proliferating cells.40 
A recent study in which RNAi experiments were carried out on S2 cultured cells in order to 
elucidate the potential role of the dE2F and RBF gene families by DNA chip, identified dNK 
as a target of dE2F1, dE2F2 and RBF1. Chromatin immunoprecipitation revealed binding of 
dE2F1 to the dNK promoter.41 We are thus able to emphasize the developmental and 
physiological significances of this regulation in normal conditions and the role for dNK when 
the de novo pathway is inhibited. 
Biochemical and phylogenetic studies have suggested that the insect progenitor was likely to 
contain several deoxyribonucleoside kinases genes. However, all genes but one (dNK, which 
encodes a TK2-like kinase) have been lost during evolution.6 Apparently, this enzyme has 
undergone a retrograde evolution, from a specialized TK2-like enzyme toward an enzyme 
with a broad specificity. Here we show that, unlike the TK2 enzyme, dNK is cell cycle 
regulated, and under the control of the dE2F1 transcription factor, like mammalian TK1. This 
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suggests that, like broad substrate specificity, cell cycle regulation of the dNK gene is also 
subjected to positive adaptative selection in Drosophila.  
As a whole, our study of the functions of dNK in Drosophila highlights its role in 
proliferation and anti-apoptotic processes, when the de novo pathway is impaired. Moreover, 
our data emphasize the importance of dT in cell survival and mass accumulation during 
development, since over- or under-expression of dNK renders flies very sensitive to the 
nucleoside and prone to cell death. Finally, our results point out the tight link between the de 
novo and salvage pathways in vivo in Drosophila. We demonstrate that dNK over-expressing 
transgenic flies are rescued from the effects of antifolate treatment. Strikingly, we describe a 
novel mechanism of resistance to antifolates, involving dNK gain of function. 
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Figure legends  
 
Figure 1 : Schematic representation of both de novo and salvage pathways of purine 
(dATP, dGTP) and pyrimidine (dTTP, dCTP) nucleotides synthesis in metazoan. 
 
Figure 2 : Imaginal discs dNK expression pattern 
(A-B) are dNK in situ hybridization of third instar wing and eye-antennae imaginal discs 
respectively. (A) Mid-late 3rd instar wing imaginal disc showing quite uniform dNK 
expression. (B) Eye-antennae imaginal disc displays specific dNK expression (arrowheads) in 
the late G1-S cells of the disc, posterior to the morphogenetic furrow (MF) (open 
arrowheads). (C) Mid-late 3rd instar wing imaginal disc staining with anti-dNK antibodies 
(left) and the DAPI nuclear dye (middle) where a uniform dNK protein expression can be 
observed as in (A). Insets clearly show a cytoplasmic localization for dNK (merge picture). 
(D) Late 3rd instar wing imaginal discs showing that dNK expression is down-regulated 
(arrowheads) in the ZNC cells along the Dorsal/ventral boundary. These cell cycle arrested 
cells do not incorporate the S phase marker : BrdU (inset). (E) Eye-antennae imaginal disc 
stained with anti-dNK (left) and anti-Cyclin E (middle) antibodies that marks cells entering S 
phase. Empty arrowheads indicate the MF ; white arrowheads indicate dNK expression. dNK 
is up-regulated in CyclinE-expressing cells (merge picture). 
 
Figure 3 : dNK expression is regulated by the dE2F1-DP factor 
(A) Ectopic expression of the dE2F1-DP factor and the caspase inhibitor P35, according to 
ptc-GAL4, triggers dNK expression (arrowheads) in the wing disc, as visualized by dNK in 
situ hybridization. (B) As in (C), dE2F1-DP and P35 expression trigger dNK protein 
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expression in the ptc domain marked by GFP (arrowheads), as visualized by anti-dNK 
antibodies. Insets show that, in this experiment also, dNK is localized in the cytoplasm. (C) 
ptc-GAL4, UAS-CycE, UAS-GFP (green) disc stained with anti-CycE antibody (blue), anti-
dNKantibodies (red) and DAPI. As for dE2F-1, dNK expression is induced in response to 
CyclinE. (D) Over-expression of RBF1 according to ptc-GAL4 represses dNK expression 
(arrowheads). RBF1 inhibits proliferation suggesting that dNK expression is involved in this 
phenomenon. (E) Wing discs over-expressing dNK according to the ptc-GAL4 driver display 
a strong dNK protein induction in the ptc domain marked by GFP (arrowheads). Insets show 
that, even when over-expressed, dNK is localized in the cytoplasm.  
 
Figure 4 : dNK expression rescues antifolates-induced cell death 
(A) Comparison of wing phenotypes in control flies (vg-GAL4 driver), df(dNK)/+ flies and 
dNK over-expressing flies according to this driver that marks the future wing margin. Wing 
phenotypes of flies reared on AM (1mg/kg) are subdivided in two classes : [+] or [notched]. 
AM-treatment induces wing nicks in the control strain. This phenotype is enhanced in 
df(dNK)/+ flies. dNK over-expression greatly rescues these wing nicks at the margin of both 
control and df(dNK)/+ strains. (n : number of wings observed).(B) en-GAL4, UAS-dNK, UAS-
GFP wing disc reared on AM (1mg/kg) and stained with anti-activated caspases antibodies 
and DAPI. GFP expression marks the posterior (P) compartment of the disc. Caspases were 
activated only in the anterior (A) compartment of the disc. (C) en-GAL4, UAS-dNK wing disc 
stained for apoptosis with TUNEL when larvae were reared on AM (1mg/kg). Strong staining 
in the A compartment of the disc is observed, whilst almost no apoptosis is detected in P cells 
rescued by dNK over-expression. (D) Upper wing : control en-GAL4 flies reared on AM 
(1mg/kg) which induces apoptosis and scalloped wings. Lower wing : dNK is over-expressed 
according to the en-GAL4 driver, in the posterior (P) compartment of the wing disc. The P 
half of the wing displays a normal structure suggesting that defects induced by the drug are 
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antagonized by dNK. (E) Percentage of viability on AM (3mg/kg) and MTX (2mg/kg). The 
viability is calculated as the ratio of the number of adult flies hatched over the number of eggs 
deposited in the medium (n). The diagram shows the relative Drosophila viability when 
reared on the drug compared to the viability on normal medium. For both drugs the control 
strain displays a viability. Heterozygous flies for a dNK deficiency of are even more severely 
impaired. dNK over-expression with the ubiquitous da-GAL4 driver confers strong resistance 
to antifolates, in both control (da-GAL4) and df(dNK)/+ strains.  
 
Figure 5 : dNK expression rescues antifolate-induced eye phenotype 
Drosophila were grown on a medium containing AM (3mg/kg) (D-F) or not. (A-C). Upon 
AM treatment, the eyes of controls remain comparable to those of controls reared on normal 
medium (A,D), while df(dNK)/+ flies display reduced eyes with a frequency of 40% (B,E). 
This eye phenotype was completely rescued when UAS-dNK was expressed under control of 
the ubiquitous driver da-GAL4, in a df(dNK)/+ genetic background (C,F). The same results 
were observed with MTX (2mg/kg). (n > 100 eyes observed for every genotype) 
 
Figure 6 : Effect of dNK expression on cell cycle transition. 
(A) Quantitative 'real-time' RT-PCR analysis performed on whole extracts of third instar 
larvae. Results show dE2F1/RP49 transcript levels in control (da-GAL4) or da-GAL4,UAS-
dNK larvae reared on medium containing AM (2mg/kg) or not. Transcript levels were 
adjusted by normalizing to the ribosomal protein RNA RP49 and were calculated relative to 
the wild type level (expression in  this genotype was set to 1). dE2F1 expression decreases in 
response to AM treatment, but this effect is significantly reduced in dNK over-expressing 
Drosophila. (B) Staged third instar wing discs over-expressing GFP (en-GAL4; UAS-GFP) 
(1,3) or dNK and GFP (en-GAL4; UAS-GFP; UAS-dNK) (2,4) in the posterior (P) 
compartment of larvae, and reared on either normal medium (1,2) or medium containing AM 
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(1mg/kg) (3,4) were analysed by cell sorter experiments. Discs were dissociated according to 
12. Cell cycle profile of the P compartment (red line) was compared to the anterior (A) 
compartment (green line). The percentages of cells in the different cycle phases in both 
compartments are indicated. Cells on the bottom lefthand side of the DNA profiles, with less 
DNA content than G1 ones, are assumed to undergo cell death. Results show that AM 
treatment significantly decreases the number of G2/M phase cells. This cell cycle phasing 
alteration is rescued by dNK over-expression in the P compartment. 
 
Figure 7 : Relationship between dNK and its substrate dT 
(A) Diagram showing the percentage of viability of a WT strain on media containing a high 
concentration of AM (10mg/kg) or not. WT flies are highly sensitive to AM10 and display an 
extremely reduced viability. Increasing concentrations of dT were added to the medium. Low 
[dT] rescues the flies’ viability to a great extent, whereas adding further dT is deleterious. 
n=500 eggs were deposited on the medium and emerging adults were collected for every 
experimental condition. (B) Quantitative 'real-time' RT-PCR analysis performed on whole 
extracts of third instar larvae. In the wild type strain, the dNK/RP49 level of transcripts in 
larvae reared on medium containing dT (2.5g/kg) is increased when compared to control. 
Nevertheless, in heterozygous df(dNK)/+ Drosophila, this dNK in response to dT addition, is 
very weak, if indeed at all. (C) Diagram showing the percentage of viability of control flies, 
da-GAL4 UAS-dNK (GOF) overexpressing flies, and df(dNK)/+ (LOF) Drosophila reared on 
increasing concentrations of dT. n=100 eggs. Each condition was repeated 10 times. For the 
three strains, viability on the control (dT 0g/kg) is similar. Until dT 2mg/kg, almost no effect 
is observed in the control strain, whereas strong lethality is observed for both the LOF and the 
GOF genotypes. (D) Third instar wing disc of control, df(dNK)/+ (LOF) and vg-GAL4, UAS-
dNK (GOF) larvae grown on dT (1,5g/kg) and stained for apoptosis with TUNEL and with the 
nuclear dye DAPI. Little cell death is detected in wild type wing discs, whereas apoptosis is 
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clearly observed for the LOF and particularly for the GOF genotypes. (E) Diagram showing 
the average mass (µg) of control and df(dNK)/+ Drosophila reared on increasing 
concentrations of dT. 50 flies (25 males + 25 females) were pooled together, frozen, 
dehydrated and weighted. Average mass of a single fly was calculated for each condition and 
representative pictures are shown. (F) Diagram showing the average size (pixels) of control 
and df(dNK)/+ Drosophila reared on increasing concentrations of dT. 100 late pupae images 
were analysed and pupae area was measured using ImageJ software. Mean area and standard 
deviation of pupae were calculated for each condition and representative pictures are shown. 
 
 
 










